AlleyCorp
Kevin Ryan's New York venture studio and early-stage fund that both incubates companies and leads pre-seed through Series A investments across healthcare, enterprise tech, and economic infrastructure.
Typical check size
$1M-$10M (stage-based estimate)
Founded
2007
Headquarters
140 W 22nd St, New York, NY 10010
AUM
N/A
Rounds they lead
Rounds they invest
Portfolio companies we track
Startups in our directory that list AlleyCorp as an investor (6 total).
- Alchemy Health End-to-end infrastructure for in-house pharmacy programs at HIV/HCV clinics.
- Clarasight AI operating system for enterprise travel and expense program management.
- Memora Health AI care navigation via SMS and phone for complex patients—acquired by Commure in 2024.
- Pearl Health Software for primary care practices participating in Medicare value-based care.
- Thyme Care Value-based oncology care navigation and support platform for cancer patients.
- Vanna Health Value-based technology-enabled care for serious mental illness (schizophrenia, bipolar).
Related investment articles
Jun 22, 2026
AlleyCorp Leads Vanna Health Round for Serious Mental Illness Care
Apr 29, 2026
AlleyCorp Leads Clarasight $11.5M Series A for Enterprise T&E AI
Aug 5, 2026
AlleyCorp Leads Avatar Robotics' $6.5M Seed: Human-in-the-Loop Humanoids
Jul 24, 2026
a16z Portfolio Companies on Fire in 2026: AI, American Dynamism & More
Jul 25, 2026
Nashville Startups and VC Firms in 2026: Health Services Capital Map
FAQs about AlleyCorp
Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.